Jamshid Farahati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jamshid Farahati has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Elena Gilman
Clinic for Nuclear Medicine, Bethesda, Duisburg
3 shared publicationsAndreas Bockisch
Clinic for Nuclear Medicine, University Hospital Essen, Germany
2 shared publicationsDietmar Kumm
Clinic for Orthopaedic, Bethesda, Duisburg, Germany
2 shared publicationsInes Maric
Clinic for Nuclear Medicine, Bethesda, Duisburg, Germany
2 shared publicationsJames Nagarajah
2 shared publicationsKen Herrmann
Clinic for Nuclear Medicine, University Hospital Essen, Germany
2 shared publications
Latest Publications
- 12 August 2019
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 154, 108853
Post-radiosynovectomy imaging utilizing Erbium-169 citrate
- 12 August 2019
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 154, 108853
Post-radiosynovectomy imaging utilizing Erbium-169 citrate
- 27 March 2019
- Published by Georg Thieme Verlag KG in Nuklearmedizin-Nuclear Medicine
- Vol. 58 (02) , 86-92
Changing trends of incidence and prognosis of thyroid carcinoma
Aim to evaluate the time trend of epidemiology of follicular cell derived thyroid cancer (TC) based on data from a well documented cancer registry. Methods Population based data on TC from Lower Franconia (LF), Germany, within 1981 and 2015 were analysed to estimate the regional epidemiology of TC. The incidence was assessed in 5-year-intervals for gender, histology, and tumor stage. Results Incidence of TC solely attributable to papillary TC (PTC) doubled mainly in T1- and T2-stages within the evaluation period from 4.5 to 8.7/100.000/y in females and 1.7 to 4.1/100.000/y in males. There was no significant change of follicular TC (FTC), whereas anaplastic TC (ATC) decreased in the same interval. The number of lymph-node metastases and T3-cases increased, while the frequency of T4-stage and distant metastases decreased. Increased incidences of T1- and T2-stages suggest an over-diagnosis. In contrast, increasing number of tumors at T3-stage and with lymph node involvement contradict the over-diagnosis as the only reason for rising incidence. Declining of T4-stages in spite of increasing of T3-stages and N1-cases indicates the value of timely detection and treatment of TC. In accordance, reduced incidence of advanced cancers with M1-stage and ATC cases promote our current management of TC. Conclusion Timely diagnosis and adequate risk-adopted treatment of thyroid cancer reduce the frequency of high-risk cases with distant metastases and the possible protracted dedifferentiation of TC to anaplastic features. Our analyses support the management algorithm in thyroid cancer according to the recent guidelines of German Nuclear Medicine Society. Ziel Evaluierung des Trends der Epidemiologie von Schilddrüsenkrebs (TC) in Unterfranken (UF). Methodik Populationsbasierte Daten aus Unterfranken aus den Jahren 1981 bis 2015 wurden analysiert und die Änderung der Inzidenz des TC ermittelt. Die Inzidenz wurde in 5-Jahres-Intervallen in Bezug auf Geschlecht, Histologie, und Tumorstadium berechnet. Ergebnisse Die TC-Inzidenz verdoppelte sich im Auswertungszeitraum, bei Frauen von 4,5 auf 8,7/100.000/J und von 1,7 auf 4,1/100.000/J bei Männern, was überwiegend den papillären Schilddrüsenkarzinomen (PTC) in T1- und T2-Stadien zuzuschreiben ist. Es gab keine signifikante Änderung beim follikulären TC (FTC), während die Häufigkeit des anaplastische TC (ATC) abnahm. Die Anzahl der Lymphknotenmetastasen und T3-Fälle stieg, während die Frequenz der T4-Fälle und der Fernmetastasen in diesem Intervall abnahm. Eine erhöhte Inzidenz von Karzinomen in T1- und T2-Stadien ließe sich durch Überdiagnostik erklären. Im Gegensatz dazu sprechen die Zunahme der Inzidenz von Tumoren in T3- und N1-Stadien gegen eine Überdiagnose als einzigen Grund für den Anstieg. Die abnehmende Zahl von Patienten mit T4-Stadium bei gleichzeitigem Anstieg der Fälle im T3- und N1-Stadium sprechen vielmehr für eine rechtzeitige Diagnose von Schilddrüsenkarzinomen. Die abnehmende Inzidenz der weit fortgeschnittenen Fälle mit Fernmetastasen und mit ATC im gleichen Zeitraum bestätigen das bei uns verfolgte Konzept. Schlussfolgerung Die rechtzeitige Diagnose und adäquate risikoadaptierte Behandlung des Schilddrüsenkarzinoms im Frühstadium reduziert die Häufigkeit von Hochrisiko-Fällen mit Fernmetastasen und verhindert die mögliche Entdifferenzierung vom DTC zu anaplastischen Tumoren. Unsere Analysen bestätigen das therapeutische Management von Schilddrüsenkrebs gemäß Leitlinien der Deutschen Gesellschaft für Nuklearmedizin.
- 27 March 2019
- Published by Georg Thieme Verlag KG in Nuklearmedizin-Nuclear Medicine
- Vol. 58 (02) , 86-92
Changing trends of incidence and prognosis of thyroid carcinoma
Aim to evaluate the time trend of epidemiology of follicular cell derived thyroid cancer (TC) based on data from a well documented cancer registry. Methods Population based data on TC from Lower Franconia (LF), Germany, within 1981 and 2015 were analysed to estimate the regional epidemiology of TC. The incidence was assessed in 5-year-intervals for gender, histology, and tumor stage. Results Incidence of TC solely attributable to papillary TC (PTC) doubled mainly in T1- and T2-stages within the evaluation period from 4.5 to 8.7/100.000/y in females and 1.7 to 4.1/100.000/y in males. There was no significant change of follicular TC (FTC), whereas anaplastic TC (ATC) decreased in the same interval. The number of lymph-node metastases and T3-cases increased, while the frequency of T4-stage and distant metastases decreased. Increased incidences of T1- and T2-stages suggest an over-diagnosis. In contrast, increasing number of tumors at T3-stage and with lymph node involvement contradict the over-diagnosis as the only reason for rising incidence. Declining of T4-stages in spite of increasing of T3-stages and N1-cases indicates the value of timely detection and treatment of TC. In accordance, reduced incidence of advanced cancers with M1-stage and ATC cases promote our current management of TC. Conclusion Timely diagnosis and adequate risk-adopted treatment of thyroid cancer reduce the frequency of high-risk cases with distant metastases and the possible protracted dedifferentiation of TC to anaplastic features. Our analyses support the management algorithm in thyroid cancer according to the recent guidelines of German Nuclear Medicine Society. Ziel Evaluierung des Trends der Epidemiologie von Schilddrüsenkrebs (TC) in Unterfranken (UF). Methodik Populationsbasierte Daten aus Unterfranken aus den Jahren 1981 bis 2015 wurden analysiert und die Änderung der Inzidenz des TC ermittelt. Die Inzidenz wurde in 5-Jahres-Intervallen in Bezug auf Geschlecht, Histologie, und Tumorstadium berechnet. Ergebnisse Die TC-Inzidenz verdoppelte sich im Auswertungszeitraum, bei Frauen von 4,5 auf 8,7/100.000/J und von 1,7 auf 4,1/100.000/J bei Männern, was überwiegend den papillären Schilddrüsenkarzinomen (PTC) in T1- und T2-Stadien zuzuschreiben ist. Es gab keine signifikante Änderung beim follikulären TC (FTC), während die Häufigkeit des anaplastische TC (ATC) abnahm. Die Anzahl der Lymphknotenmetastasen und T3-Fälle stieg, während die Frequenz der T4-Fälle und der Fernmetastasen in diesem Intervall abnahm. Eine erhöhte Inzidenz von Karzinomen in T1- und T2-Stadien ließe sich durch Überdiagnostik erklären. Im Gegensatz dazu sprechen die Zunahme der Inzidenz von Tumoren in T3- und N1-Stadien gegen eine Überdiagnose als einzigen Grund für den Anstieg. Die abnehmende Zahl von Patienten mit T4-Stadium bei gleichzeitigem Anstieg der Fälle im T3- und N1-Stadium sprechen vielmehr für eine rechtzeitige Diagnose von Schilddrüsenkarzinomen. Die abnehmende Inzidenz der weit fortgeschnittenen Fälle mit Fernmetastasen und mit ATC im gleichen Zeitraum bestätigen das bei uns verfolgte Konzept. Schlussfolgerung Die rechtzeitige Diagnose und adäquate risikoadaptierte Behandlung des Schilddrüsenkarzinoms im Frühstadium reduziert die Häufigkeit von Hochrisiko-Fällen mit Fernmetastasen und verhindert die mögliche Entdifferenzierung vom DTC zu anaplastischen Tumoren. Unsere Analysen bestätigen das therapeutische Management von Schilddrüsenkrebs gemäß Leitlinien der Deutschen Gesellschaft für Nuklearmedizin.
- Open Access
- 12 May 2017
- Published by Wiley in Clinical Case Reports
- Vol. 5 (6) , 1048-1050
Post‐radiosynovectomy imaging of Er‐169 using scintigraphy and autoradiography
Key Clinical Message: Currently, there is no protocol for the detection of intra‐articular distribution of Er‐169 citrate after radiosynovectomy. We propose post‐therapeutic imaging using scintigraphy and cobalt‐57 pen‐marker autoradiography. This technique evaluates the efficacy of the radiosynovectomy and patient safety and could be utilized for dosimetric protocol.
- 12 May 2017
- Published by Wiley in Clinical Case Reports
- Vol. 5 (6) , 1048-1050
Open AccessPost‐radiosynovectomy imaging of Er‐169 using scintigraphy and autoradiography
Key Clinical Message: Currently, there is no protocol for the detection of intra‐articular distribution of Er‐169 citrate after radiosynovectomy. We propose post‐therapeutic imaging using scintigraphy and cobalt‐57 pen‐marker autoradiography. This technique evaluates the efficacy of the radiosynovectomy and patient safety and could be utilized for dosimetric protocol.
- Open Access
- 27 October 2016
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 44 (3) , 459-460
"la synoviorthèse" can more than synovitis!
- 27 October 2016
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 44 (3) , 459-460
Open Access"la synoviorthèse" can more than synovitis!
- Open Access
- 1 January 2016
- Published by Scitechnol Biosoft Pvt. Ltd. in Translational Biomedicine
- Vol. 7 (3)
Parity and Iodine Status are Predictive Factors for Goitre Prevalence in Females
Background: To evaluate the predictive factors of goitre prevalence in females. Methods: In a questionnaire-based survey, data from 370 female employees aged between from 4 institutions in western part of Germany was collected between April 2001 and April 2002 and the association between parity and simple goitre was examined with respect to age, daily use of iodized salt, contraceptives, the history of goitre in the first degree relatives and smoking. Ultrasound of the neck was performed in all cases to determine the thyroid volume. Logistic regression analyses were performed to adjust for age, iodine status, parity, contraceptives, familial history of goitre and smoking. Results: The overall prevalence of goitre was (80/370) 21.6%. Median thyroid volume Goitre was present in 44 out of 140 parous (31.4%) vs. 34/220 (15.5%) in nulliparous (odds ratio: 2.5; p<0.001). Indeed, the linear regression shows a positive association of the thyroid volume with increasing age (p=0.023), the number of cigarettes in a week (p=0.001) and its negative association with duration of contraceptive intake (p=0.005), no association with iodine intake or parity could be detected. However, the logistic regression analysis revealed significant association only between goitre prevalence and parity (p=0.004), and lack of daily iodized salt intake (p=0.01), whereas, age (p=0.18), contraceptive (p=0.82), the familial history of goitre (p=0.33) and smoking (p=0.09) did not affect the goitre prevalence. Conclusions: Parity and iodine status are predictive factors of goitre prevalence in females.
- 1 January 2016
- Published by Scitechnol Biosoft Pvt. Ltd. in Translational Biomedicine
- Vol. 7 (3)
Open AccessParity and Iodine Status are Predictive Factors for Goitre Prevalence in Females
Background: To evaluate the predictive factors of goitre prevalence in females. Methods: In a questionnaire-based survey, data from 370 female employees aged between from 4 institutions in western part of Germany was collected between April 2001 and April 2002 and the association between parity and simple goitre was examined with respect to age, daily use of iodized salt, contraceptives, the history of goitre in the first degree relatives and smoking. Ultrasound of the neck was performed in all cases to determine the thyroid volume. Logistic regression analyses were performed to adjust for age, iodine status, parity, contraceptives, familial history of goitre and smoking. Results: The overall prevalence of goitre was (80/370) 21.6%. Median thyroid volume Goitre was present in 44 out of 140 parous (31.4%) vs. 34/220 (15.5%) in nulliparous (odds ratio: 2.5; p<0.001). Indeed, the linear regression shows a positive association of the thyroid volume with increasing age (p=0.023), the number of cigarettes in a week (p=0.001) and its negative association with duration of contraceptive intake (p=0.005), no association with iodine intake or parity could be detected. However, the logistic regression analysis revealed significant association only between goitre prevalence and parity (p=0.004), and lack of daily iodized salt intake (p=0.01), whereas, age (p=0.18), contraceptive (p=0.82), the familial history of goitre (p=0.33) and smoking (p=0.09) did not affect the goitre prevalence. Conclusions: Parity and iodine status are predictive factors of goitre prevalence in females.
- Open Access
- 1 January 2016
- Published by Scitechnol Biosoft Pvt. Ltd. in Translational Biomedicine
- Vol. 7 (3)
Increasing of Iodine Intake Decrease the High Risk of Goitre in Smoking Men
Background: An association between smoking and the risk of goitre is reported in some, but not all studies. We investigated the association between smoking, goitre and iodine intake, with respect to different risk factors in 483 healthy men in Germany. Methods: A total of 483 healthy male employees of 4 institutions in Essen in Western part of Germany, aged between 17 and 68 years (43.1 ± 9.6 y) were examined by ultrasound of the neck to determine the thyroid volume between April 2001 and April 2002. Information on age, BMI, smoking, daily use of iodized salt, and familial history of thyroid disorders were assessed by standardized questionnaires. Logistic regression analysis was performed to adjust for smoking, age, iodine status and familial history of goitre. Results: The overall prevalence of goitre was 25.7%. Median thyroid volume among smokers, (23.4 ± 10.1 ml), was higher (p<0.001) as compared with non-smokers (19.4 ± 7.8 ml). Goitre was present in 77 out of 204 smokers (37.7%) vs. 47/279 (16.8%) in non-smokers (odds ratio: 3.0; p<0.001). Smoking (p<0.001) and increasing age (p<0.001) was associated with goitre prevalence, but not BMI and the family history of goitre. Iodine status alone failed just to reach the significance level but revealed a clear trend. And there was significant prevalence of goitre in smoking men who did not take iodine salt compared to smoking men with regular intake of iodine salt (p=0.018). Conclusions: Smoking increase the risk of goitre in men that can be decreased by taking iodine.
- 1 January 2016
- Published by Scitechnol Biosoft Pvt. Ltd. in Translational Biomedicine
- Vol. 7 (3)
Open AccessIncreasing of Iodine Intake Decrease the High Risk of Goitre in Smoking Men
Background: An association between smoking and the risk of goitre is reported in some, but not all studies. We investigated the association between smoking, goitre and iodine intake, with respect to different risk factors in 483 healthy men in Germany. Methods: A total of 483 healthy male employees of 4 institutions in Essen in Western part of Germany, aged between 17 and 68 years (43.1 ± 9.6 y) were examined by ultrasound of the neck to determine the thyroid volume between April 2001 and April 2002. Information on age, BMI, smoking, daily use of iodized salt, and familial history of thyroid disorders were assessed by standardized questionnaires. Logistic regression analysis was performed to adjust for smoking, age, iodine status and familial history of goitre. Results: The overall prevalence of goitre was 25.7%. Median thyroid volume among smokers, (23.4 ± 10.1 ml), was higher (p<0.001) as compared with non-smokers (19.4 ± 7.8 ml). Goitre was present in 77 out of 204 smokers (37.7%) vs. 47/279 (16.8%) in non-smokers (odds ratio: 3.0; p<0.001). Smoking (p<0.001) and increasing age (p<0.001) was associated with goitre prevalence, but not BMI and the family history of goitre. Iodine status alone failed just to reach the significance level but revealed a clear trend. And there was significant prevalence of goitre in smoking men who did not take iodine salt compared to smoking men with regular intake of iodine salt (p=0.018). Conclusions: Smoking increase the risk of goitre in men that can be decreased by taking iodine.
- 1 January 2006
- Published by Springer Nature in Biological Trace Element Research
- Vol. 113 (3) , 223-230
Gender-Specific Determinants of Goiter
Despite the strong implications of differences between females and males in the risk of goiter, gender-specific issues have not been extensively addressed in investigations of goiter prevalence. The objective of our analysis was to investigate the gender-specific determinants of goiter. Between April 2001 and April 2002. A total of 853 healthy employees from 4 institutions in the western part of Germany between 18 and 68 yr of age were examined by ultrasound of the neck to determine the thyroid volume. Information on sex, age, daily use of iodized salt, the history of goiter in the first-degree relatives, type and amount of smoking, oral contraceptives, and number of pregnancies were assessed by standardized questionnaires. Gender-specific predictors of goiter prevalence were assessed by multivariate logistic regression. The overall prevalence of goiter among study subjects was 204/853 (23.9%). Goiter was present in 80 out of 370 females (21.6%) vs 124/483 (25.7%) in males. In general, smoking (ppp=0.004) were associated with goiter prevalence, but not sex (p=0.39) and family history of goiter (p=0.16). In 370 females, parity (p=0.004) and lack of daily intake of iodized salt (p=0.01) were the major determinants for goiter, whereas age (p=0.18), oral contraceptives (p=0.82), family history of goiter (p=0.33), and smoking (p=0.09) did not affect goiter prevalence. In 483 males, smoking (ppp=0.39), and the iodine status failed just to reach the significant level (p=0.08) in this analysis. Gender-specific determinants of goiter are parity and iodine status in females and smoking and increasing age in males.
- 1 January 2006
- Published by Springer Nature in Biological Trace Element Research
- Vol. 113 (3) , 223-230
Gender-Specific Determinants of Goiter
Despite the strong implications of differences between females and males in the risk of goiter, gender-specific issues have not been extensively addressed in investigations of goiter prevalence. The objective of our analysis was to investigate the gender-specific determinants of goiter. Between April 2001 and April 2002. A total of 853 healthy employees from 4 institutions in the western part of Germany between 18 and 68 yr of age were examined by ultrasound of the neck to determine the thyroid volume. Information on sex, age, daily use of iodized salt, the history of goiter in the first-degree relatives, type and amount of smoking, oral contraceptives, and number of pregnancies were assessed by standardized questionnaires. Gender-specific predictors of goiter prevalence were assessed by multivariate logistic regression. The overall prevalence of goiter among study subjects was 204/853 (23.9%). Goiter was present in 80 out of 370 females (21.6%) vs 124/483 (25.7%) in males. In general, smoking (ppp=0.004) were associated with goiter prevalence, but not sex (p=0.39) and family history of goiter (p=0.16). In 370 females, parity (p=0.004) and lack of daily intake of iodized salt (p=0.01) were the major determinants for goiter, whereas age (p=0.18), oral contraceptives (p=0.82), family history of goiter (p=0.33), and smoking (p=0.09) did not affect goiter prevalence. In 483 males, smoking (ppp=0.39), and the iodine status failed just to reach the significant level (p=0.08) in this analysis. Gender-specific determinants of goiter are parity and iodine status in females and smoking and increasing age in males.
- 1 December 1996
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 144 (1-2) , 59-63
Cardiac involvement in facio-scapulo-humeral muscular dystrophy: a family study using Thallium-201 single-photon-emission-computed tomography
- 1 December 1996
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 144 (1-2) , 59-63
Cardiac involvement in facio-scapulo-humeral muscular dystrophy: a family study using Thallium-201 single-photon-emission-computed tomography